The next goal for weight loss drugs? Fewer injections

For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss.

For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It may be fewer injections.

Subscribe to read this story ad-free

Get unlimited access to ad-free articles and exclusive content.

Pfizer and Amgen are developing monthly GLP-1 shots — a departure from injections like Wegovy and Zepbound, which are taken weekly.

The goal, the drugmakers say, is to make weight loss drugs more convenient and easier to stick with.